Furthermore, Marker et al. [46] estimated the genetic ancestry of 1,928 BC tumors from Hispanic/Latino women residing in Peru, Mexico, and Colombia, finding that the likelihood of having an HER2-positive tumor grew by a factor of 1.20 for every 10.0% increase in the proportion of IA ancestry. Here, ERBB2 is linked to breast cancer.